Bevirimat

An inhibitor of HIV-1 virion maturation

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥1300.00

1040.00

- +
10mg

￥2175.00

1740.00

- +
50mg

￥0.00

0.00

- +
100mg

￥0.00

0.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajce55258
CAS: 174022-42-5
别名: 贝韦立马; PA-457; MPC-4326; YK FH312
分子式: C36H56O6
分子量: 584.83
纯度: >98%
溶解度: DMSO: ≥ 50 mg/mL (85.49 mM); Water: < 0.1 mg/mL (insoluble)
储存: Store at -20°C
库存: 现货

Background

PA-457 is an inhibitor of HIV-1 virion maturation.^1,2 It inhibits the cleavage of the Gag capsid (CA) precursor CA-SP1 to the mature CA protein. PA-457 inhibits the replication of drug-sensitive and -resistant clinical isolates of HIV-1 in isolated human peripheral blood mononuclear cells (PBMCs; mean IC₅₀s = 10.3 and 7.8 nM, respectively).³ In vivo, it prevents replication of HIV-1 in SCID-hu Thy/Liv mice when administered at a dose of 100 mg/kg.⁴

1.Martin, D.E., Salzwedel, K., and Allaway, G.P.Bevirimat: A novel maturation inhibitor for the treatment of HIV-1 infectionAntivir. Chem. Chemother.19(3)107-113(2008) 2.Wang, D., Lu, W., and Li, F.Pharmacological intervention of HIV-1 maturationActa Phatm. Sin. B5(6)493-499(2015) 3.Li, F., Goila-Gaur, R., Salzwedel, K., et al.PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processingProc. Natl. Acad. Sci. USA100(23)13555-13560(2003) 4.Soddart, C.A., Joshi, P., Sloan, B., et al.Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv micePLoS One2(11)e1251(2007)